Abstract
The death of a fetus in utero is a tragic event irrespective of gestation. The importance of appropriate psychological support for the parents at such a time is well recognised and has been reviewed recently [1]. This chapter will focus on the clinical management of antepartum fetal death from 20 weeks gestation with particular reference to IUGR.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Fox R, Pillai M, Porter J, Gill G. The management of late fetal death: a guide to comprehensive care. Br J Obstet Gynaecol 1998;104–10.
Department of Health. Confidential enquiries into stillbirth and deaths in infancy; 4th Annual Report, 1 January-31 December 1995. London: DoH, 1997.
Hadlock FP, Harrist RB, Martinez-Poyer J. In-utero analysis of fetal growth: a sonographic weight standard. Radiology 1991;181:129–33
Gardosi J, Mul T, Mongelli M, Fagan D. Analysis of birthweight and gestational age in antepartum stillbirths. Br J Obstet Gynaecol 1998;105:524–30.
Department of Health. Confidential enquiries into stillbirth and deaths in infancy; 4th Annual Report, 1 January-31 December 1995. London: DoH, 1997.
Guzman ER, Benito CW, Vintizeleos AM, et al. Intrauterine growth restriction prior to 24 weeks of gestation associated with abnormal uterine and umbilical artery Doppler velocimetry [abstract]. J Soc Gynecol Invest 1996;3: 240A.
Valcamonico A, Danti L, Frusca T, et al. Absent end-diastolic velocity in umbilical artery: risk of neonatal morbidity and brain damage. Am J Obstet Gynecol 1994;170:796–801.
Kingdom JCP, Rodeck CH, Kaufmann R Umbilical artery Doppler — more harm than good? Br J Obstet Gynaecol 1997;104:393–6.
Nolan RL. The maternal abdomen and pelvis in pregnancy. In: Sauerbrei EE, Nguyen KT, Nolan RL, editors. A practical guide to ultrasound in obstetrics and gynaecology, 2nd edn. New York: Lippincott-Raven, 1998;503–35.
Kellner KR, Donnelly WH, Gould SD. Parental behaviour after perinatal death: lack of predictive demographic and obstetric variables. Obstet Gynecol 1984;63:809–14.
Weiner AE, Reid DE, Roby CC, Diamond LK. Coagulation defects with intrauterine death from Rh isosensitization. Am J Obstet and Gynaecol 1950;60:1015–21.
Pritchard JA, Ratnoff OD. Studies of fibrinogen and other haemostatic factors in women with intrauterine death and delayed surgery. Surg Gynaecol Obstet 1995;10:467–77.
Pritchard JA. Fetal death in utero. Obstet Gynaecol 14:573–80.
Pritchard JA. Haematological problems associated with delivery, placental abruption, retained dead fetus, and amniotic fluid embolism. Clin Haematol 1973;2(3):563–86.
Baglin T. Disseminated intravascular coagulation: diagnosis and management. BMJ 1996;312: 683–7.
c.
Colman R, Robboy S, Minna J. Disseminated intravascular coagulation (DIC): an approach. Am J Med 1972;52;679–87.
Seigel T, Seligsohn U, Agahi E, Modan M. Clinical and laboratory aspects of DIC; A study of 118 cases. Thromb Haemost 1978;39:122–34.
Spero J, Lewis J, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost 1980;3:28–33.
Carr J, Mckinney M, McDonnagh J. Diagnosis of disseminated intravascular coagulation. Role of D-dimer. Am J Clin Pathol 1989;91:280–7.
Williams E. Disseminated intravascular coagulation. In: Loscalzo J, Schäfer A, editors. Thrombosis and haemorrhage. Boston: Blackwell Science 1994;921–44.
Urquhart DR. Therapeutic abortion; methods used in the second trimester. Curr Obstet Gynaecol 1993;3:17–22.
Wagatsuma T. Intra amniotic injection of saline for therapeutic abortion. Am J Obstet Gynaecol 1993;93:743–5.
MacDonald D, O’Driscoll MK, Geoghegan FJ. Intra-amniotic dextrose - a maternal death. J Obstet Gynaecol Br Commonwealth 1965;72:452–5.
Mahomed K, Jayaguru A. Extra amniotic saline infusion for induction of labour in ante-partum fetal death: a cost effective method worthy of wider use. Br J Obstet Gynaecol 1997;104(9): 1058–61.
Hill NCW, MacKenzie IZ. 2308 second trimester terminations using extra-amniotic or intra- amniotic prostaglandin E2: an analysis of efficacy and complications. Br J Obstet Gynaecol 1989;96:1421–31.
Sakamoto S, Satoh K, Nishiya I, Kunimoto K, Chimura T, Oda T. Abortifacient effect and uterine cervix—dilating action of 16,16—dimethyl—trans—delta2 PGE 1 methylester(0N0802) in the form of a vaginal suppository (a randomized double-blind controlled study in the second trimester of pregnancy). Prostaglandins Leukotrienes 1982;9:349–61.
Thong KJ, Robertson AJ, Baird DT. Retrospective study of 932 second trimester terminations using gemeprost (16,16 dimethyl-trans PGE1 methyl ester). Prostaglandins 1992;44:65–74.
Urquhart DR, Templeton AA. Mifepristone and second trimester pregnancy Lancet 1987;ii: 1405.
Roger MW, Baird DT. Pretreatment with mifepristone (RU486) reduces the interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990;97:41–5.
Aubeny E, Baulieu EE. Activité contragestive de 1 association auRU486 d'une Prostaglandine active par voie orale. CR Acad Sci III 1991;312:539–45.
El-Refaey H, Hinshaw K, Templeton A. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone(RU486). Hum Reprod 1993;8(10):1744–6.
El-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 1995;10(2):475–8.
Bugalho A, Bique C, Almeidia L, Faundes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 1993;24:319–23.
Marguilies M, Perez MC, Vato L. Misoprostol to induce labour. Lancet 1992;339:64.
Report on confidential enquiries into maternal deaths in England and Wales. HMSO, 1997.
Enborm JA. Twin pregnancy with intrauterine death of one twin. Am J Obstet Gynaecol 1985;152:429–9.
D'Alton ME, Newton ER, Cetrulo A. Intrauterine fetal demise in multiple gestation. Acta Genet Med Gemellol 1984;33:43–9.
Murphy K. Intrauterine death in a twin: implications for the survivor. In: Ward RH, Whittle M, editors. Multiple pregnancy. London: RCOG Press, 1995.
Pinette MG, Pan Y, Pinette SG, Stubblefield PG. Treatment of twin–to–twin transfusion syndrome. Obstet Gynecol 1993;82:841–6.
Trespidi L, Boschetto C, Caravelli E, Villa L, Kustermann A, Nicolini U. Serial amniocentesis in the management of twin—to—twin transfusion syndrome: when is it valuable? Fetal Diagn Ther 1997;12:15–20.
Dippel AL. Bull Johns Hopkins Hosp 1934;54:24.
Brenner B, Blumfield Z. Thrombophilia and fetal loss. Blood Rev. 1997; 11:72–9.
Salafia CM, Ernst LM, Pezz. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol 1995;12(2):106–10.
Allen MC. Developmental outcome and follow-up of the small for gestational age infant. Semin Perinatol 1984;8:123–9.
Taylor DI. Low birth weight and neurodevelopmental handicap. Clin Obstet Gynecol 1984;11:525–31.
Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E, Yagami Y. Beta 2-glycoprotein I—independent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996;11:509–12.
Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993;100:909–13.
Draycott TJ, Kaloo P, Locke R, Fox R, Smith P, Read M. A case—control study of anticardiolipin antibodies after unexplained fetal loss from 24 weeks of gestation(abstract). Br J Obstet Gynaecol 1996;103:484.
Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042–8.
Preston FE, Rosendale FR, Walker ID. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913–16.
Sanson BJ, Friederich PW, Simioni P. The risk of abortion and stillbirth in anti—thrombic—protein C-and protein S-deficient women. Thromb Haemost 1996;75:387–8.
Maternal and Neonatal Haemostasis Working Party. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol 1993;46:489–96.
Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994;369:64–7.
Waters. UK Collaborative Study: Solid tissue culture in clinical cytogenetics. Association Clinical Cytogeneticists Working Party Report.
Thornton CM, O’Hara MD. A regional audit of perinatal and infant autopsies in Northern Ireland. Br J Obstet Gynecol 1998;105:18–23.
Weston MJ, Porter HJ, Andrews HS, Berry PJ. Correlation of antenatal ultrasonography and pathological examination in 153 malformed fetuses. J Clin Ultrasound 1993;21:387–92.
Joint Working Party of the Royal College of Pathologists and Royal College of Obstetricians and Gynaecologists. Report on fetal and perinatal pathology. London: Royal College of Obstetricians and Gynaecologists, 1988.
Royal College of Pathologists. Guidelines for post mortem reports. London: Royal College of Pathologists, 1993.
Rushton DI. West Midlands perinatal mortality survey: an audit of 300 perinatal autopsies. Br J Obstet Gynaecol 1991;98:624–7.
El-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Hum Reprod 1995;10(2):475–8.
Bugalho A, Bique C, Almeidia L, Faundes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann 1993;24:319–23.
Marguilies M, Perez MC, Vato L. Misoprostol to induce labour. Lancet 1992;339:64.
Report on confidential enquiries into maternal deaths in England and Wales. HMSO, 1997.
Enborm JA. Twin pregnancy with intrauterine death of one twin. Am J Obstet Gynaecol 1985;152:429–9.
D’Alton ME, Newton ER, Cetrulo A. Intrauterine fetal demise in multiple gestation. Acta Genet Med Gemellol 1984;33:43–9.
Murphy K. Intrauterine death in a twin: implications for the survivor. In: Ward RH, Whittle M, editors. Multiple pregnancy. London: RCOG Press, 1995.
Pinette MG, Pan Y, Pinette SG, Stubblefield PG. Treatment of twin-to-twin transfusion syndrome. Obstet Gynecol 1993;82:841–6.
Trespidi L, Boschetto C, Caravelli E, Villa L, Kustermann A, Nicolini U. Serial amniocentesis in the management of twin-to-twin transfusion syndrome: when is it valuable? Fetal Diagn Ther 1997;12:15–20.
Dippel AL. Bull Johns Hopkins Hosp 1934;54:24.
Brenner B, Blumfield Z. Thrombophilia and fetal loss. Blood Rev. 1997; 11:72–9.
Salafia CM, Ernst LM, Pezz. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol 1995;12(2):106–10.
Allen MC. Developmental outcome and follow-up of the small for gestational age infant. Semin Perinatol 1984;8:123–9.
Taylor DI. Low birth weight and neurodevelopmental handicap. Clin Obstet Gynecol 1984;11:525–31.
Katano K, Aoki A, Sasa H, Ogasawara M, Matsuura E, Yagami Y. Beta 2-glycoprotein I-independent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996;11:509–12.
Pattison NS, Chamley LW, McKay EJ, Liggins GC, Butler WS. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. Br J Obstet Gynaecol 1993;100:909–13.
Draycott TJ, Kaloo P, Locke R, Fox R, Smith P, Read M. A case-control study of anticardiolipin antibodies after unexplained fetal loss from 24 weeks of gestation(abstract). Br J Obstet Gynaecol 1996;103:484.
Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042–8.
Preston FE, Rosendale FR, Walker ID. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913–16.
Sanson BJ, Friederich PW, Simioni P. The risk of abortion and stillbirth in anti-thrombic-protein C-and protein S-deficient women. Thromb Haemost 1996;75:387–8.
Maternal and Neonatal Haemostasis Working Party. Guidelines on the prevention, investigation and management of thrombosis associated with pregnancy. J Clin Pathol 1993;46:489–96.
Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H. Mutation in blood coagulation factor V associated with resistance to activated Protein C. Nature 1994;369:64–7.
Waters. UK Collaborative Study: Solid tissue culture in clinical cytogenetics. Association Clinical Cytogeneticists Working Party Report.
Thornton CM, O’Hara MD. A regional audit of perinatal and infant autopsies in Northern Ireland. Br J Obstet Gynecol 1998;105:18–23.
Weston MJ, Porter HJ, Andrews HS, Berry PJ. Correlation of antenatal ultrasonography and pathological examination in 153 malformed fetuses. J Clin Ultrasound 1993;21:387–92.
Joint Working Party of the Royal College of Pathologists and Royal College of Obstetricians and Gynaecologists. Report on fetal and perinatal pathology. London: Royal College of Obstetricians and Gynaecologists, 1988.
Royal College of Pathologists. Guidelines for post mortem reports. London: Royal College of Pathologists, 1993.
Rushton DI. West Midlands perinatal mortality survey: an audit of 300 perinatal autopsies. Br J Obstet Gynaecol 1991;98:624–7.
Wright C, Cameron H, Lamb W. A study of the of perinatal autopsy in the former Northern region. Br J Obstet Gynaecol 1998;105:24–8.
Fox H. The placenta in intrauterine growth retardation: Ward RHT, Smith SK, Donnai D, editors. Early fetal growth and development. London: RCOG press, 1994;23–44.
Fox H. Non-trophoblastic tumours of the placenta. In: Fox, editor. Obstetrical and gynaecological pathology, 3rd edn. Edinburgh, Churchill Livingstone, 1030–44.
Salafia CM, Vintzileos AM, Silberman L. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol 1992;9:179–84.
Stioui S, de Silvestris M, Molinari A. Trisomie 22 placenta in a case of severe intrauterine growth retardation. Prenat Diagn 1989;9:673–6.
Schwinger B, Seidl B, Klink F. Chromosome mosaicism of the placenta—a cause of development failure of the fetus? Prenat Diagn 1989;9:639–47.
Giles WB, Trudinger BJ, Baird PJ. Fetal umbilical artery flow velocity wavelengths and placental resistance: pathological correlation. Br J Obstet Gynaecol 1985;92:31–8.
Jackson MR, Walsh AJ, Morrow RJ, Mullen JBM, Lye SJ, Knox-Ritchie JW. Reduced placental villous tree elaboration in small-for-gestational age pregnancies: relationship with umbilical artery Doppler waveforms. Am J Obstet Gynecol 1995;172:518–25.
Krebs C, Macara LM, Leiser R, Bowman AWF, Greer IA, Kingdom JCP. Intrauterine growth restriction with absent end—diastolic flow velocity in the umbilical artery is associated with maldevelopment of the terminal placental villous tree. Am J Obstet Gynecol 1996;175:1534–42.
Rains CP, Bryson HM, Fitton A. Cabergoline. Drugs 1995;49:255–79.
Iffy L. Lethal cardiovascular complications in patients receiving bromocriptine for ablactation. Medical law 1995;14:99–104.
Kuno N, Itakura A, Kurachi O, Mizutani S, Kazeto S, Tomoda Y. Decrease in severity of intrauterine growth retardation in subsequent pregnancies. Int J Gynaecol Obstet 1995;51:219–24.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag London Limited
About this chapter
Cite this chapter
Chipchase, J., Peebles, D.M. (2000). Management of Antepartum Fetal Death. In: Kingdom, J., Baker, P. (eds) Intrauterine Growth Restriction. Springer, London. https://doi.org/10.1007/978-1-4471-0735-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4471-0735-4_17
Publisher Name: Springer, London
Print ISBN: 978-1-4471-1191-7
Online ISBN: 978-1-4471-0735-4
eBook Packages: Springer Book Archive